-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $8

Benzinga·05/13/2026 20:17:27
Listen to the news
Lake Street analyst Frank Takkinen maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and lowers the price target from $10 to $8.